Metabolic syndrome and depressive symptoms among Japanese men and women

Abstract

Objectives Evidence is limited on the relation between metabolic syndrome and depressive symptoms. The aim of this cross-sectional study was to investigate the association between metabolic syndrome and depressive symptoms in a Japanese working population. Methods The study subjects comprised 458 municipal employees (age range 21-67 years) from two municipal offices in Japan. A modified version of the criteria of the National Cholesterol Education Program Adult Treatment Panel III was used to define metabolic syndrome. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES_D) scale. Results Depressive symptoms (CES_D C 16) in both the male and female subjects were not significantly associated with metabolic syndrome nor with each component of metabolic syndrome. In men, high fasting glucose was associated with increased prevalence of severe depressive state (CES_D C 23). Conclusions Metabolic syndrome may not be associated with depressive status among Japanese employees.

Metabolic syndrome and depressive symptoms among rural Northeast general population in China

“…However, after stratified by gender, depressive symptoms were associated with TG component only in women but not in men. Yasumi Kimura and colleagues claimed that depressive symptoms was associated with fasting hyperglycemia while Sang Jin Rhee announced that HDL component was associated with depressive symptoms in women [37, 38]. In our study, women with depressive symptoms had significantly higher value of glucose, TG and HDL components than those without them which was similar with the previous studies [37, 38].…”

“…Yasumi Kimura and colleagues claimed that depressive symptoms was associated with fasting hyperglycemia while Sang Jin Rhee announced that HDL component was associated with depressive symptoms in women [37, 38]. In our study, women with depressive symptoms had significantly higher value of glucose, TG and HDL components than those without them which was similar with the previous studies [37, 38]. In especial, the prevalence of elevated TG in our study was dramatically higher than the other studies also held in Asia areas.…”

Prevalence and Predictors of Metabolic Syndrome in People With Schizophrenia in Inpatient Rehabilitation Wards

“…Studies of people with schizophrenia conducted in Belgium (Vancampfort, Probst, et al, 2012) and Thailand (Suttajit & Pilakanta, 2013) and in the general populations of Japan (Sekita et al, 2013), Greece (Tziallas et al, 2012), the United Kingdom (Akbaraly et al, 2009), and Taiwan (Lin, Liang, Liao, & Tsay, 2014) have shown that very severe depressive symptoms are associated with a high risk of developing MetS. Maslov et al (2009) and Kimura, Matsushita, Nanri, and Mizoue (2011) investigated people with schizophrenia and found no correlation between depressive symptoms and MetS. Maslov et al (2009) and Sekita et al (2013) found that the number of depressive symptoms increased progressively with the number of MetS components in the general male population.…”

Metabolic syndrome in drug-naïve patients with Depressive Disorders

“…[456] In contrast, the studies which have evaluated the prevalence of MS and depression (as a disorder or as subsyndromal depression) in patients attending general hospitals or the community-based population have evaluated 215 to 6,189 subjects and have reported a prevalence rate of MS between 11.7 and 57%. [78910111213141516171819202122232425] These studies suggest that the presence of depression increases the risk of development of MS by twofold. [720]…”